These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4945027)

  • 1. [False-positive ocular pigmentation during administration of neuroleptics].
    Tidsskr Nor Laegeforen; 1971 Dec; 91(35):2575-6. PubMed ID: 4945027
    [No Abstract]   [Full Text] [Related]  

  • 2. Ocular (pigmentary) effects of psychotropic drugs.
    Appleton WS; Shader RI; DiMascio A
    Conn Med; 1970 Jan; 34(1):25-8. PubMed ID: 4903792
    [No Abstract]   [Full Text] [Related]  

  • 3. Chlorpromazine-induced skin pigmentation with corneal and lens opacities.
    Huff LS; Prado R; Pederson JF; Dunnick CA; Lucas LM
    Cutis; 2014 May; 93(5):247-50. PubMed ID: 24897137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular changes produced by chlorpromazine.
    Dencker SJ; Enoksson P
    Acta Ophthalmol (Copenh); 1966; 44(3):397-403. PubMed ID: 5953234
    [No Abstract]   [Full Text] [Related]  

  • 5. Ocular changes associated with chlorpromazine therapy. A preliminary report.
    Edler K
    Acta Ophthalmol (Copenh); 1966; 44(3):405-9. PubMed ID: 5953235
    [No Abstract]   [Full Text] [Related]  

  • 6. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)].
    Gol'dovskaia IL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472
    [No Abstract]   [Full Text] [Related]  

  • 7. Corneal deposition after high-dose chlorpromazine hydrochloride therapy.
    Webber SK; Domniz Y; Sutton GL; Rogers CM; Lawless MA
    Cornea; 2001 Mar; 20(2):217-9. PubMed ID: 11248834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ocular involvement during prolonged treatment with neuroleptics].
    Nouri A; Cuendet JF
    Schweiz Med Wochenschr; 1968 Oct; 98(43):1708-11. PubMed ID: 4974196
    [No Abstract]   [Full Text] [Related]  

  • 9. The prevalence of the ocular side effects of chlorpromazine in the Tuscaloosa Veterans Administration patient population.
    Alexander LJ; Bowerman L; Thompson LR
    J Am Optom Assoc; 1985 Nov; 56(11):872-6. PubMed ID: 4078212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total dosage of chlorpromazine and ocular opacities.
    Buffaloe WJ; Johnson AW; Sandifer MG
    Am J Psychiatry; 1967 Aug; 124(2):250-1. PubMed ID: 4951587
    [No Abstract]   [Full Text] [Related]  

  • 11. Ocular side effects of chlorpromazine in a child.
    Geiger LA; Lesser LL
    JAMA; 1967 Nov; 202(9):916. PubMed ID: 6072668
    [No Abstract]   [Full Text] [Related]  

  • 12. Corneal and lenticular opacities in mentally retarded young adults treated with thioridazine and chlorpromazine.
    Gualtieri CT; Lefler WH; Guimond M; Staye JI
    Am J Psychiatry; 1982 Sep; 139(9):1178-80. PubMed ID: 7114312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlorpromazine-induced severe skin pigmentation and corneal opacities in a patient with schizophrenia.
    Molina-Ruiz AM; Pulpillo Á; Molina-Ruiz RM; Sagrario T; Requena L
    Int J Dermatol; 2016 Aug; 55(8):909-12. PubMed ID: 26340849
    [No Abstract]   [Full Text] [Related]  

  • 14. Presumed corneal copper deposition and oral contraceptive use.
    Orlin A; Orlin SE; Makar GA; Bunya VY
    Cornea; 2010 Apr; 29(4):476-8. PubMed ID: 20168218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular and cutaneous side effects after prolonged chlorpromazine treatment.
    Gombos GM; Yarden PE
    Am J Psychiatry; 1967 Jan; 123(7):872-4. PubMed ID: 6016858
    [No Abstract]   [Full Text] [Related]  

  • 16. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    Lal S; Bloom D; Silver B; Desjardins B; Krishnan B; Thavundayil J; Thompson T
    J Psychiatry Neurosci; 1993 Jul; 18(4):173-7. PubMed ID: 8104031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlorpromazine corneal toxicity.
    Johnson AW; Buffaloe WJ
    South Med J; 1968 Sep; 61(9):993-4. PubMed ID: 5676587
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of promazine and chlorpromazine metabolites on the cornea.
    Adams HR; Manian AA; Steenberg ML; Buckley JP
    Adv Biochem Psychopharmacol; 1974; 9(0):281-93. PubMed ID: 4836207
    [No Abstract]   [Full Text] [Related]  

  • 19. Blue skin pigmentation and chlorpromazine.
    Haddad RI
    J Ky Med Assoc; 1977 Mar; 75(3):124-6. PubMed ID: 839129
    [No Abstract]   [Full Text] [Related]  

  • 20. In vivo observations of a case of chlorpromazine deposits in the cornea using an HRT II Rostock corneal module.
    Toshida H; Uesugi Y; Ebihara N; Murakami A
    Cornea; 2007 Oct; 26(9):1141-3. PubMed ID: 17893554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.